(Corrects amount raised in IPO to “64.80 billion rupees” from “73.87 billion rupees” in paragraph 1)
BENGALURU, Nov 20 (Reuters) - Shares of India’s Gland Pharma rose as much as 20% in their market debut on Friday after raising 64.80 billion rupees ($873.79 million) in India’s largest initial public offering by a pharmaceutical company.
Established in 1978 and backed by China-based Shanghai Fosun Pharmaceutical Group Co Ltd, Gland Pharma is a major provider of injectable generic drugs and sells its products in over 60 countries, including the United States, Canada and Europe.
The stock opened at 1,710 rupees per share, higher than the IPO price of 1,500 rupees per share, giving the company a market value of 279.21 billion rupees, based on 163.3 million shares outstanding. ($1 = 74.1600 Indian rupees) (Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Anil D’Silva)
Our Standards: The Thomson Reuters Trust Principles.